An initial pharmacokinetic study with a Metered Dose Transdermal System® for delivery of the progestogen Nestorone® as a possible future contraceptive☆
To access this article, please choose from the options below
☆ Funding for this study was provided jointly by the Population Council and Acrux Ltd.
PII: S0010-7824(07)00409-X
doi:10.1016/j.contraception.2007.08.006
© 2007 Elsevier Inc. All rights reserved.
